Daytrana: A Long and Winding Road to Approval

On April 6, 2006, the FDA announced the approval of Daytrana, a transdermal patch version of Ritalin (methylphenidate). While you wouldn’t know it by the gushy promotional copy on Daytrana’s website (, the Ritalin patch just barely squeaked through the FDA approval process.

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.